Article
CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
29 Jan 2010
Abstract excerpt
BACKGROUND: Aberrant beta-catenin signaling plays a key role in several cancer types, notably colon, liver and breast cancer. However approaches to modulate beta-catenin activity for therapeutic purposes have proven elusive to date. METHODOLOGY: To uncover genetic dependencies in breast cancer cells that harbor active beta-catenin signaling, we performed RNAi-based loss-of-function screens in breast cancer cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
